Category: Articles

GreenLight laser surgery is at least as effective as the TURP, concludes NICE in new guidance

We welcome the new NICE guidance which recognises GreenLight laser surgery is at least as effective as the older TURP operation and carries fewer risks and complications. The latest guidance from the National Institute for Health and Care Excellence (NICE) is based on detailed analysis of studies of patient outcomes from both types of surgery […]

Read more

We are pleased to publish forthcoming speakers and talk titles for the Prostate Cancer Support Group

The group meets in Solihull on the last Tuesday of each month and is open to all patients and people affected by prostate cancer, regardless of where they are receiving treatment. The speaker programme features consultants and senior nurses from leading teaching hospitals, covering many different aspects of treatment, recovery, common questions and concerns.   […]

Read more

Not too young for prostate cancer. Richard Rollings describes his experience of developing prostate cancer in his forties.

When Richard Rollings had an elevated PSA result in his forties, he was initially told he was too young to get prostate cancer. Yet further tests revealed he did have the disease and five years later, Richard speaks about the need for prompt action and early diagnosis. “I noticed something wasn’t right: I’d get the […]

Read more

What is Cyberknife treatment like for prostate cancer? – James Derbyshire*

James Derbyshire* is one of the first patients to have the state-of-the-art Cyberknife treatment in Birmingham. The intensive and extremely accurate technology reduces the number of sessions from 37 to just five. Mr Derbyshire, who is 72, describes his experience. “My prostate cancer was diagnosed purely by chance and persistence. It started with some slightly […]

Read more

Outlook for men with advanced prostate cancer improved

Ahmed El-Modir, consultant oncologist Birmingham Prostate Clinic   The outlook for men with advanced prostate cancer has been transformed in recent years. A decade ago, once prostate cancer had spread beyond the prostate capsule, options were very limited. The most common scenario was hormone therapy for 18 to 24 months, followed by chemotherapy for approximately […]

Read more

How do I choose between different treatments for prostate cancer?

For men with organ-confined early stage disease, there is a wider range of different treatments for prostate cancer than any other type of cancer. Mr Alan Doherty, consultant urologist at the Birmingham Prostate Clinic, discusses the relative merits and disadvantages of the different types of treatment, answering the questions patients most commonly ask in clinic. […]

Read more

What every man should know about prostate cancer

What is my risk of prostate cancer? Prostate cancer is the most common male cancer, affecting one in every nine men. Your personal risk doubles if you have a first degree relative (father or brother) with the disease, particularly if they develop prostate cancer before the age of 60. Prostate cancer risk is also increased […]

Read more